MedImmune, the biologics research and development arm of AstraZeneca, recently joined the Human Vaccines Project to develop vaccines and immunotherapies for infectious diseases and cancer, according to a press release.
The Human Vaccines Project aims to accelerate vaccine development by deciphering the human immune system with the support of leading academic research centers, governments and nonprofit groups.